Robert Raffa

Summary

Affiliation: Temple University
Country: USA

Publications

  1. ncbi Intracerebroventricular opioids for intractable pain
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Br J Clin Pharmacol 74:34-41. 2012
  2. ncbi CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant)
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 37:260-5. 2012
  3. ncbi QTc interval prolongation by d-propoxyphene: what about other analgesics?
    Robert B Raffa
    Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
    Expert Opin Pharmacother 13:1397-409. 2012
  4. ncbi Fixed-dose combinations for emerging treatment of pain
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, 3307 N Broad Street, PA 19140, USA
    Expert Opin Pharmacother 13:1261-70. 2012
  5. ncbi Multi-mechanistic analgesia for opioid-induced hyperalgesia
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 37:125-7. 2012
  6. ncbi The evolving understanding of the analgesic mechanism of action of flupirtine
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 37:4-6. 2012
  7. ncbi Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Eur J Pharmacol 556:89-90. 2007
  8. ncbi Modified 'Joyce model' of opioid dependence/withdrawal
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, Philadelphia PA 19140, USA
    Eur J Pharmacol 551:54-7. 2006
  9. ncbi Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Brain Res 1114:31-5. 2006
  10. ncbi Short introduction and history
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Adv Exp Med Biol 678:1-10. 2010

Research Grants

  1. Joint Action Analysis of Poly-drug Withdrawal
    Robert Raffa; Fiscal Year: 2006

Collaborators

Detail Information

Publications71

  1. ncbi Intracerebroventricular opioids for intractable pain
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Br J Clin Pharmacol 74:34-41. 2012
    ..Intracerebroventricular infusion of opioid analgesics thus appears to be a safe and effective therapy for the palliative treatment of refractory pain...
  2. ncbi CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant)
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 37:260-5. 2012
    ..It is generally assumed that these compounds are CB₁ 'selective' and produce their effects exclusively via CB₁ receptors...
  3. ncbi QTc interval prolongation by d-propoxyphene: what about other analgesics?
    Robert B Raffa
    Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
    Expert Opin Pharmacother 13:1397-409. 2012
    ..Of those for which there is a lot of data, only methadone, oxycodone, and LAAM (levo--acetylmethadol) appear to have a known and accepted level of effect on the QT interval...
  4. ncbi Fixed-dose combinations for emerging treatment of pain
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, 3307 N Broad Street, PA 19140, USA
    Expert Opin Pharmacother 13:1261-70. 2012
    ..The optimal efficacy and side-effect ratio must be determined in a scientifically rigorous manner...
  5. ncbi Multi-mechanistic analgesia for opioid-induced hyperalgesia
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 37:125-7. 2012
    ..Our objective is to briefly summarize the basic science and clinical evidence about OIH as background to consider the possible benefit of using a multi-mechanistic analgesic approach...
  6. ncbi The evolving understanding of the analgesic mechanism of action of flupirtine
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 37:4-6. 2012
    ..Our objective was to trace the evolution of the understanding of flupirtine's mechanism of analgesic action to its current status...
  7. ncbi Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Eur J Pharmacol 556:89-90. 2007
    ..01) of certain ratios of this combination was possible. This synergy, here analyzed with the latest (nonlinear) isobolographic methodology, is now quantitatively established for the first time...
  8. ncbi Modified 'Joyce model' of opioid dependence/withdrawal
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, Philadelphia PA 19140, USA
    Eur J Pharmacol 551:54-7. 2006
    ..We report excellent fit of the data (R(2)=0.96) by adding: (1) a transient early phase, and (2) a delay in the buildup of protein...
  9. ncbi Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Brain Res 1114:31-5. 2006
    ..The concept that certain combinations of drugs leads to attenuated withdrawal might generalize to humans...
  10. ncbi Short introduction and history
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Adv Exp Med Biol 678:1-10. 2010
    ..This chapter introduces the reader to the fascinating and complex challenges-to patients, healthcare providers, basic scientists, employers, insurers and others-inherent in this topic and the current state of knowledge about it...
  11. ncbi Patient's perspective
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Adv Exp Med Biol 678:11-2. 2010
    ..The deficits are reported to persist. The magnitude of the negative impact on quality of life depends, as does the condition itself, on multiple and varied factors. This chapter relates the experience of one patient...
  12. ncbi Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Eur J Pharmacol 540:200-1. 2006
    ..The results provide further evidence of a kappa-opioid-like receptor in planarians...
  13. ncbi Combination strategies for pain management
    Robert B Raffa
    Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Expert Opin Pharmacother 4:1697-708. 2003
    ..This review examines the multiple basic science, clinical and pharmacoeconomic issues relating to analgesic combinations and the methodologies available for assessing these issues...
  14. ncbi Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Eur J Pharmacol 564:88-93. 2007
    ....
  15. ncbi Diselenium, instead of disulfide, bonded analogs of conotoxins: novel synthesis and pharmacotherapeutic potential
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Life Sci 87:451-6. 2010
    ..The technique results in analogs that retain the folding of the native peptides, are more potent, and have the same or greater biological activity...
  16. ncbi The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Brain Res 1193:51-6. 2008
    ..These results provide evidence that the withdrawal from cocaine and amphetamine, but not cannabinoids, in planarians is mediated through a common nor-BNI-sensitive (kappa-opioid receptor-like) pathway...
  17. ncbi Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
    J Pharmacol Exp Ther 325:500-6. 2008
    ..No synergistic effect on seizure induction was observed between concomitant tramadol and codeine or morphine...
  18. ncbi Basic pharmacology relevant to drug abuse assessment: tramadol as example
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19104, USA
    J Clin Pharm Ther 33:101-8. 2008
    ..There is nothing unique about tramadol in this regard, but its multimodal mechanism of action, pharmacologically active enantiomers, and active metabolite make it a particularly instructive and relevant example...
  19. ncbi Oxycodone combinations for pain relief
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
    Drugs Today (Barc) 46:379-98. 2010
    ..As with all combinations, the profile of adverse effects must also be determined in order to provide the clinician with the overall benefit/risk assessment...
  20. ncbi The determination and application of fixed-dose analgesic combinations for treating multimodal pain
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    J Pain 11:701-9. 2010
    ..Such measure can help clinicians who seek to maximize therapeutic effect while simultaneously minimizing adverse effects...
  21. ncbi Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'
    R B Raffa
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 35:1-9. 2010
    ..The relatively few such studies, and fewer electrophysiological studies, offer an alternative way to evaluate changes that might be related to cognitive deficits in patients treated with cancer chemotherapeutic regimens...
  22. ncbi Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?
    R B Raffa
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 31:129-38. 2006
  23. ncbi Imaging as a means of studying chemotherapy-related cognitive impairment
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Adv Exp Med Biol 678:70-6. 2010
    ..Neuroimaging techniques might offer additional insight. This chapter is a succinct summary of a more expanded review of the relatively few such studies...
  24. ncbi Opioid formulations designed to resist/deter abuse
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Drugs 70:1657-75. 2010
    ..Nevertheless, these formulations are important innovations and warrant further study to assess their appropriate role as analgesics...
  25. ncbi Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment
    R B Raffa
    Temple University School of Pharmacy RBR, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 36:437-45. 2011
    ..Our objective is to review and to comment on the basic science and clinical evidence of potential pharmacologic targets for managing this emerging concern...
  26. ncbi kappa-Opioid withdrawal in Planaria
    Robert B Raffa
    Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Neurosci Lett 349:139-42. 2003
    ..These data provide pharmacologic evidence of a kappa-opioid receptor-mediated withdrawal phenomenon and neuroadaptation to a pharmacologic stimulus (adaptations in transduction mechanisms) in this model...
  27. ncbi Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example
    R B Raffa
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 36:283-98. 2011
    ..Therefore, the elucidation of the mechanism(s) of action of natural products is important, but presents significant challenges. This article examines this issue using peroxide oil (essential oxygen oil) as an illustrative example...
  28. ncbi Disruption of a drug-induced choice behavior by UV light
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Behav Pharmacol 14:569-71. 2003
    ..05) by UV light (366 nm and 254 nm). The results demonstrate alteration of a relatively complex choice behavior by UV light...
  29. ncbi Mechanism of action of analgesics used to treat osteoarthritis pain
    Robert B Raffa
    Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
    Rheum Dis Clin North Am 29:733-45. 2003
    ..e., it often originates from multiple causes and is transmitted by multiple mediators). Therefore, the choice of the analgesics for the patient who has OA should be based upon the most appropriate mechanisms of action...
  30. ncbi Protonation effect on drug affinity
    Robert B Raffa
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA
    Eur J Pharmacol 483:323-4. 2004
    ..The results demonstrate the importance of protonation in measures of affinity...
  31. ncbi A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog')
    R B Raffa
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 36:257-9. 2011
    ..Our objective is to comment on a proposed mechanism for 'chemo-fog'...
  32. ncbi Opioid receptors and acetaminophen (paracetamol)
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
    Eur J Pharmacol 503:209-10. 2004
    ..These findings further implicate endogenous opioids (viz., endorphins, enkephalins, and dynorphins) and their pathways as contributors to the central antinociceptive action of acetaminophen...
  33. ncbi Bacterial communication ("quorum sensing") via ligands and receptors: a novel pharmacologic target for the design of antibiotic drugs
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140 5101, USA
    J Pharmacol Exp Ther 312:417-23. 2005
    ..Such drugs would have novel mechanisms of action and might therefore be more effective against antibiotic-resistant strains of bacteria...
  34. ncbi Topiramate-antagonism of L-glutamate-induced paroxysms in planarians
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Eur J Pharmacol 649:150-3. 2010
    ..3-3 mM) inhibited L-glutamate-induced paroxysms. These results provide further evidence of a topiramate-sensitive glutamate receptor-mediated activity in this model...
  35. ncbi Amphetamine-induced increase in planarian locomotor activity and block by UV light
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Brain Res 1031:138-40. 2005
    ..These findings strengthen the hypothesis that the effects of dopaminergic ligands and UV light on pLMV relate to interaction with neurotransmitter transduction process(es)...
  36. ncbi Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced 'chemo-fog'
    R B Raffa
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 35:249-55. 2010
    ....
  37. ncbi Future directions
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Adv Exp Med Biol 678:165-7. 2010
    ..The chapters of this book summarize much of what has been done and reported regarding cancer chemotherapy-related cognitive impairment. In this chapter, we point out some future directions for investigation...
  38. ncbi Chemotherapy-related visual system toxicity
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Adv Exp Med Biol 678:113-8. 2010
    ..This chapter is a succint summary of a more expanded review...
  39. ncbi The M5 muscarinic receptor as possible target for treatment of drug abuse
    R B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 34:623-9. 2009
    ....
  40. ncbi Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine
    Zhe Ding
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Br J Pharmacol 157:831-43. 2009
    ..Buprenorphine displays attributes of opioids, but also some features distinct from them. We examined spinal and supraspinal signal transduction of buprenorphine-induced anti-nociception in mice compared with morphine and fentanyl...
  41. ncbi The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Eur J Pharmacol 584:278-84. 2008
    ....
  42. ncbi Pharmacological aspects of successful long-term analgesia
    Robert Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Suite 540, Philadelphia, PA 19140 5101, USA
    Clin Rheumatol 25:S9-15. 2006
    ..Laboratory studies have demonstrated that these agents interact to produce synergistic analgesia with a desirable safety/efficacy profile...
  43. ncbi Withdrawal-like behavior in planarians is dependent on drug exposure duration
    Steve Sacavage
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA
    Neurosci Lett 439:84-8. 2008
    ..The present results suggest that the magnitude of withdrawal-like behavior in planarians is dependent on both the duration and type of drug exposure, and that planarians do not display withdrawal to caffeine...
  44. ncbi Toward the design of ribonuclease (RNase) inhibitors: ion effects on the thermodynamics of binding of 2'-CMP to RNase A
    Shawn D Spencer
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 N. Broad Street, Philadelphia, PA 19140, USA
    J Pharmacol Exp Ther 301:925-9. 2002
    ..These data should be useful for molecular modeling and suggest that inhibitor activity will be a function of cellular conditions (normal or pathological)...
  45. ncbi Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose
    Sumiyo Umeda
    Temple University School of Pharmacy, 3307 N. Broad Street, Philadelphia, PA 19140, USA
    Brain Res 1018:181-5. 2004
    ....
  46. ncbi Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition
    Shawn D Spencer
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, Pennsylvania 19140, USA
    Pharm Res 21:1642-7. 2004
    ..Isothermal titration calorimetry (ITC) and progress curve analysis was used to measure the enzyme kinetic parameters (KM and kcat) of the hydrolysis of cCMP by RNase-A, a reaction that includes end-product competitive inhibition by 3'-CMP...
  47. ncbi Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice
    Ronald J Tallarida
    Department of Pharmacology, Temple University School of Medicine, 3420 N Broad Street, Philadelphia, PA 19140 5104, USA
    J Pharmacol Exp Ther 307:699-704. 2003
    ....
  48. ncbi Description and quantification of cocaine withdrawal signs in Planaria
    Robert B Raffa
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Brain Res 1032:200-2. 2005
    ..Compared to the cocaine/cocaine group, the cocaine/water group displayed a significant number of atypical behaviors, providing direct evidence of a 'withdrawal phenomenon' in planarians...
  49. ncbi Measurement of glutamate and aspartate in Planaria
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia, PA 19140, USA
    J Pharmacol Toxicol Methods 53:291-5. 2006
    ....
  50. ncbi Harmonic mean relationship between affinity for wild-type receptors and alanine-scan mutants
    Robert B Raffa
    Temple University School of Pharmacy and School of Medicine, 3307 N Broad St 602 00, Philadelphia, PA 19140 5193, USA
    J Theor Biol 218:207-14. 2002
    ..The harmonic mean was found to be a good estimator when applied to the published data from 14 alanine-scan studies. This result is consonant with the present understanding of ligand-receptor interactions...
  51. ncbi A nitric oxide synthase inhibitor (L-NAME) attenuates abstinence-induced withdrawal from both cocaine and a cannabinoid agonist (WIN 55212-2) in Planaria
    Scott M Rawls
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Brain Res 1099:82-7. 2006
    ..These results suggest a common NO-dependent pathway of withdrawal from cocaine and WIN 55212-2 in Planaria...
  52. ncbi Toward RNase inhibitors: thermodynamics of 2'-CMP/RNase-A binding in multi-ion buffer
    Robert B Raffa
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 N Broad Street, Philadelphia, PA 19140, USA
    Biochem Pharmacol 63:1937-9. 2002
    ..90 kcal/mol; DeltaH degrees =-15.7 kcal/mol; and DeltaS degrees =-0.028 kcal/mol-K ('enthalpy-driven' interaction). These data should assist drug design of small-molecule inhibitors of homologous RNase catalytic domains...
  53. ncbi An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2)
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Temple University School of Medicine, Philadelphia, PA 19140, USA
    Pharmacol Biochem Behav 86:499-504. 2007
    ..The present results reveal that NMDA receptor activation mediates the development of cannabinoid physical dependence and the expression of cannabinoid withdrawal in planarians...
  54. ncbi 5-HT(1A)-like receptor activation inhibits abstinence-induced methamphetamine withdrawal in planarians
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA
    Neurosci Lett 484:113-7. 2010
    ....
  55. ncbi Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5)
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    Eur J Pharmacol 575:103-4. 2007
    ..This is the first demonstration of a TRPM8/TRPA1 channel subtype agonist-induced differential pharmacological effect in invertebrates and provides a novel sensitive, quantifiable end-point for studying TRP channel pharmacology...
  56. ncbi Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Synapse 62:927-34. 2008
    ..This suggests that a change in agmatine signaling is a common mechanism in the withdrawal caused by these drugs, at least in planarians...
  57. ncbi Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians
    Scott M Rawls
    Department of Pharmaceutical Sciences and Pharmacology, Temple University School of Pharmacy and Medicine, Philadelphia, PA 19140, United States
    Pharmacol Biochem Behav 93:363-7. 2009
    ..The present results provide pharmacologic evidence of a functional inhibitory action of topiramate on glutamate receptor activity in invertebrates and provide a sensitive, quantifiable end-point for studying anti-seizure pharmacology...
  58. ncbi On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data
    Ronald J Tallarida
    Department of Pharmacology, Temple University School of Medicine and Center for Substance Abuse Research, 3420 N Broad Street, Philadelphia, PA 19140, United States
    Drug Alcohol Depend 109:126-9. 2010
    ..This novel technique offers possible insight into the dual low-dose (analgesic), high-dose (addiction medication) uses of buprenorphine...
  59. ncbi Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians
    Scott M Rawls
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy and Center for Substance Abuse Research, Philadelphia, PA 19140, USA
    Neuropeptides 42:229-37. 2008
    ....
  60. ncbi First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians
    Scott M Rawls
    Department of Pharmaceutical Sciences, Center for Substance Abuse Research, Temple University Health Sciences Center, 3307 North Broad Street, Philadelphia, PA 19140, USA
    Behav Pharmacol 21:301-13. 2010
    ....
  61. ncbi Looking beyond the administered drug: metabolites of opioid analgesics
    Swati Nagar
    Temple University School of Pharmacy, Philadelphia, PA, USA
    J Fam Pract 57:S25-32. 2008
  62. ncbi Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory
    John J Foley
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, PA 19140, USA
    Psychopharmacology (Berl) 199:527-38. 2008
    ..The concern that adjuvant cancer chemotherapy agents cause cognitive impairment in a significant number of patients has been expressed by patients and healthcare providers, but clinical studies have yielded conflicting results to date...
  63. ncbi Behavioral characterization of serotonergic activation in the flatworm Planaria
    Martilias S Farrell
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania 19140, USA
    Behav Pharmacol 19:177-82. 2008
    ....
  64. ncbi A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria
    Sumiyo Umeda
    Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 N. Broad Street, Philadelphia, PA 19140, USA
    J Pharmacol Toxicol Methods 51:73-6. 2005
    ....
  65. ncbi Liquid chromatography-mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma
    Hongfei Yue
    Department of Chemistry, Temple University, Philadelphia, PA 19140, USA
    J Pharmacol Toxicol Methods 52:314-22. 2005
    ..Assay accuracy and precision of back-calculated standards were within +/-15%. DISCUSSION: This method will be useful for investigation of buprenorphine's mechanism of action and clinical profile...
  66. ncbi The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations
    Ronald J Tallarida
    Department of Pharmacology, School of Medicine, Center for Substance Abuse Research RJT, Temple University, Philadelphia, PA 19140, USA
    Pharmacol Ther 127:165-74. 2010
    ..New formulas derived to assess the statistical variance for additive combinations are included, and the more detailed mathematical topics are included in the Appendix...
  67. ncbi Role of pharmacogenetics in variable response to drugs: focus on opioids
    Esin Kadiev
    Temple University School of Pharmacy, 3307 N Broad Street, Philadelphia PA 19140, USA
    Expert Opin Drug Metab Toxicol 4:77-91. 2008
    ..The role of genetic variability in clinical opioid therapy is examined, and relevant clinical trials cited. The present status of opioid pharmacogenetics, promises and challenges and future directions are discussed...
  68. ncbi Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats
    Robert J Schulingkamp
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA, USA
    Pharmacology 74:23-30. 2005
    ..These results suggest compensatory mechanisms in receptor number and abnormalities in 2nd messenger transduction and can help direct efforts for improving antihypertensive or other pharmacological therapy for diabetic patients...
  69. ncbi Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids
    Anne Schock Citver
    Temple University School of Pharmacy, Philadelphia, PA 19140, USA
    J Clin Pharm Ther 27:161-8. 2002
    ....
  70. ncbi Acetaminophen and metabolite: lack of effect on nitric oxide synthase (constitutive or inducible)
    Robert B Raffa
    Headache 42:237-8. 2002
  71. ncbi LiCl attenuates M(1)AChR-mediated intrathecal pilocarpine-induced reciprocal hindlimb scratching in mice
    Rebecca P Martinez
    Johnson and Johnson Pharmaceutical Research and Development, L.L.C, Spring House, Pa. 19140, USA
    Pharmacology 65:210-4. 2002
    ..These findings provide in vivo evidence for a possible link between RHS and a LiCl-sensitive, possibly phosphoinositide-related, effector pathway...

Research Grants3

  1. Joint Action Analysis of Poly-drug Withdrawal
    Robert Raffa; Fiscal Year: 2006
    ..g., electrophysiologic or molecular biology techniques. An improved understanding of how withdrawal is influenced by poly-drug abuse could lead to development of enhanced clinical treatment. ..